Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GERN $3.45 0.4000 +13.11%
PVCT $0.42 0.0400 +10.53%
BLRX $1.69 0.1100 +6.96%
CALA $5.99 0.3500 +6.21%
VRML $2.23 0.0800 +3.72%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

KERX $5.06 -0.9700 -16.09%
TGTX $11.46 -1.0600 -8.47%
TLOG $2.26 -0.2000 -8.13%
IMDZ $15.77 -1.1500 -6.80%
MRTX $25.98 -1.8600 -6.68%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next > | Last >>

Imaging Probe Outperforms the Best External Detector for Early Cervical Cancer

(ICR [UK]) Aug 20, 2015 - An endovaginal magnetic resonance imaging technique is more accurate at detecting early-stage cervical cancer than the best widely available method, a new study reports.
read article 



An Easy Pairing

(Fred Hutch) Aug 19, 2015 - Fred Hutch's Harlan Robins develops a new method to match thousands of pairs of key genes needed for cancer immunotherapy.
read article 



Lynparza Improves Overall Survival in High-Risk Gastric Cancer

(MedPage Today) Aug 19, 2015 - The combination of olaparib (Lynparza) and paclitaxel was active in patients with metastatic gastric cancer, with an overall survival (OS) benefit relative to paclitaxel alone in patients with low or undetectable levels of a DNA damage response gene known as ATM, researchers said.
read article (free registration required) 



Study: Fewer Moles May Mean More Aggressive Melanoma

(American Academy of Dermatology) Aug 20, 2015 - People with more than 50 moles have an increased risk of developing melanoma, the deadliest form of skin cancer, but those with fewer than 50 moles should still be alert for this disease.
read press release 



Early-Stage Breast Condition May Not Require Cancer Treatment

(New York Times) Aug 20, 2015 - As many as 60,000 American women each year are told they have a very early stage of breast cancer — Stage 0, as it is commonly known — a possible precursor to what could be a deadly tumor.
read article 



New Kind of Cancer Study Finds New Targets for Tailored Treatments

(NBC News) Aug 20, 2015 - A new kind of cancer study supports the idea that traditional treatment can be turned on its head, with patients given targeted therapy based not on where their tumors started but on their own genetic mutations.
read article 



Memorial Sloan Kettering Cancer Center Researchers Publish Landmark “Basket Study”

(MSK) Aug 19, 2015 - Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
read press release 



Novartis Drug Odomzo® Gains EU Approval for Locally Advanced Basal Cell Carcinoma, Providing New Non-Invasive Therapy for Patients

(MarketWatch) Aug 20, 2015 - Novartis announced today that the European Commission has approved Odomzo® (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) who are not amenable to curative surgery or radiation therapy.
read article 



Black Women Less Likely to Survive Uterine Cancer

(WebMD/HealthDay News) Aug 19, 2015 - Uterine cancer rates are rising in the United States, particularly among black and Asian women, according to a new study that also found black women are more likely to die of the disease.
read article 



The NCI Community Cancer Centers Program Has Positive Impact in Nebraska

(ASCO in Action) Aug 19, 2015 - A new study published on August 11 in the Journal of Oncology Practice demonstrates the feasibility of a National Cancer Institute (NCI) program to advance cancer research and improve quality of care in a rural community setting.
read article 



Lundbeck Surges as New CEO Cuts 17% of Jobs to Fight Generics

(Bloomberg) Aug 19, 2015 - H. Lundbeck A/S shares surged as Chief Executive Officer Kaare Schultz, just three months on the job, said he’ll cut about 17 percent of the workforce as the drugmaker fights generic competition.
read article 



Roche Snaps Up Gene Sequencing Group Kapa

(PharmaTimes [UK]) Aug 19, 2015 - Roche is pulling private gene-sequencing firm Kapa Biosystems under its wing for an undisclosed amount in a move to ramp up its offering in next-generation sequencing.
read article 



FDA Warns Mylan About Violations At Indian Plants

(Pittsburgh Post-Gazette) Aug 18, 2015 - The U.S. Food and Drug Administration cited local generic drug giant Mylan for "significant violations" of manufacturing regulations at three plants in India, according to a warning letter released by the agency.
read article 



Amgen to Pay $71 Million To States For Promoting Off-Label Drug Uses

(Los Angeles Times) Aug 18, 2015 - Amgen Inc. has agreed to pay $71 million to settle allegations by 48 state attorneys general that it improperly marketed two of its blockbuster drugs.
read article (free registration required) 



FDA Approves Controversial ‘Little Pink Pill’ But With Restrictions

(MSNBC/NBCNews.com) Aug 19, 2015 - The Food and Drug Administration has approved a pill that aims to increase a woman’s desire for sex — a controversial decision made only after an extended lobbying campaign by the drug’s makers.
read article 



Jimmy Carter to Discuss Cancer Diagnoses Thursday

(CNN) Aug 18, 2015 - Former President Jimmy Carter has scheduled a Thursday morning news conference to discuss his cancer diagnosis.
read article 



Maryland Governor: 95 Percent of Cancer Gone

(New York Times/Associated Press) Aug 19, 2015 - After eight weeks of intensive treatment, Maryland Gov. Larry Hogan says 95 percent of his cancer is gone.
read article 



NY Expands Colorectal Cancer Screening With Federal Money

(North Country Public Radio/Associated Press) Aug 18, 2015 - New York is using $8 million in federal funding to expand screenings for colorectal cancer.
read article 



E-Cigarettes Can Help Smokers Quit, Review Says

(NASDAQ/Dow Jones Business News) Aug 19, 2015 - Electronic cigarettes are less harmful than smoking traditional cigarettes and can be effective tools to help smokers quit, according to a review published Wednesday by Public Health England, a government agency.
read article 



First Defendant in Fake Cancer-Drug Case to Be Arraigned

(Wall Street Journal) Aug 18, 2015 - The first defendant will be arraigned in U.S. federal court next week in connection with an indictment involving Canada Drugs, the Winnipeg-based company accused of selling counterfeit drugs in the U.S.
read article (paid subscription required) 



AbbVie Buys Special Review Voucher For $350 Million

(Reuters) Aug 19, 2015 - AbbVie Inc has bought a priority review voucher from United Therapeutics Corp for $350 million that will allow it to accelerate the review process for one of its drugs.
read article 



Mylan Confirms First-to-File Patent Challenge Relating to Zytiga®

(MarketWatch) Aug 18, 2015 - Mylan N.V. today confirmed that the company has been sued by BTG International Ltd., Janssen Biotech, Inc., Janssen Oncology, Inc., and Janssen Research & Development, LLC in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Abiraterone Acetate Tablets, 250 mg.
read article 



ASCO’s Quality Training Program Leads to Improvement Learning in Oncology

(ASCO in Action) Aug 18, 2015 - A new article published in the Journal of Oncology Practice studies how structured training programs improve health professionals’ skills in performing clinical care and research.
read article 



These Companies Are Teaming Up To Fight Cancer With Data

(Fortune) Aug 19, 2015 - Two cancer technology startups said Wednesday that are teaming up to collaborate on using big data to help improve cancer treatment and diagnosis.
read article 



Madison Vaccines Announces Patient Dosing Underway in Clinical Trial Pairing Its Lead Prostate Cancer Vaccine, MVI-816, with PD1 Inhibitor Pembrolizumab

(MarketWatch) Aug 19, 2015 - Madison Vaccines Incorporated (MVI) today announced dosing has begun in a combination trial for MVI-816 (pTVG-HP), its lead prostate cancer vaccine, paired with pembrolizumab (Keytruda®), a PD-1 inhibitor, also called a checkpoint inhibitor.
read article